Clinical Trials Browser

Phase 2 × Disease × abiraterone × Clear all

NCT07299292 2025-12-23

Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)

Phase 2 Recruiting

Disease, Prostatic Neoplasms